You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gp100

Showing 1 - 25 of 1,542
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
Has Results
  • Melanoma
  • gp100
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
  • Amsterdam, Netherlands
    The Amsterdam University Medical Centers
Aug 2, 2023

Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
  • (no location specified)
May 8, 2023

Melanoma (Skin) Trial in Tampa (biological, drug, procedure)

Active, not recruiting
  • Melanoma (Skin)
  • NY-ESO-1 157-165 (165V)
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Healthy Volunteers Trial in Shanghai ([14C] GP681)

Completed
  • Healthy Volunteers
  • [14C] GP681
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Nov 28, 2021

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)

Recruiting
  • Healthy Adults
  • Sitravatinib 50 mg
  • +3 more
  • Dallas, Texas
    Labcorp Drug Development Clinical Research Unit
Feb 23, 2022

Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

Active, not recruiting
  • Healthy
  • Ad26.Mos4.HIV
  • +2 more
  • Birmingham, Alabama
  • +52 more
Jan 17, 2023

Melanoma (Skin) Trial in Madison (gp100 antigen, sargramostim)

Completed
  • Melanoma (Skin)
  • gp100 antigen
  • sargramostim
  • Madison, Wisconsin
    University of Wisconsin Comprehensive Cancer Center
Nov 15, 2019

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Turoctocog alfa pegol)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • Turoctocog alfa pegol
  • Phoenix, Arizona
  • +66 more
Dec 20, 2022

Malignant Melanoma Trial in Haikou (GPA-TriMAR-T)

Unknown status
  • Malignant Melanoma
  • GPA-TriMAR-T
  • Haikou, Hainan, China
  • +1 more
Dec 5, 2019

Melanoma Trial in Houston (Leuprolide, GP100: 209-217(210M) Peptide, MAGE-3 Peptide)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 27, 2019

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Active, not recruiting
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +69 more
Mar 18, 2022

Nasopharyngeal Tumors Trial in Guangzhou (IMRT using individualized CTV, IMRT using traditional CTV, Gemcitabine and cisplatin

Unknown status
  • Nasopharyngeal Neoplasms
  • IMRT using individualized CTV
  • +5 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 13, 2020

Congenital Bleeding Disorder, Haemophilia B Trial in Worldwide (nonacog beta pegol)

Active, not recruiting
  • Congenital Bleeding Disorder
  • Haemophilia B
  • nonacog beta pegol
  • Los Angeles, California
  • +63 more
Nov 30, 2021

Melanoma (Skin) Trial in Rochester (MART-1 antigen, IL-2, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Feb 15, 2019

Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Sep 19, 2022

Bodily Distress Syndrome, Functional Somatic Disorder Trial in Silkeborg (Diagnostic evaluation at the Diagnostic Clinic for

Recruiting
  • Bodily Distress Syndrome
  • Functional Somatic Disorder
  • Diagnostic evaluation at the Diagnostic Clinic for Functional Disorders
  • Diagnostic as usual
  • Silkeborg, Denmark
    Regionshospitalet Silkeborg
Aug 29, 2023

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Uveal Melanoma Trial (Tebentafusp)

Available
  • Uveal Melanoma
  • (no location specified)
Jan 5, 2022

Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

Not yet recruiting
  • Epstein-Barr Virus Infection
  • +2 more
  • Matrix-M1 Adjuvant
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Asthma, Breast Tumors, Coronary Disease Trial (gp-multitool.de)

Not yet recruiting
  • Asthma
  • +6 more
  • gp-multitool.de
  • (no location specified)
Sep 24, 2023